Pikkelysömör: vizsgálatok itt: Bulgária
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 1. fázisTaking peopleA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Lovech, Pleven, Plovdiv
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036 - 3. fázisTaking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Burgas, Lovech, Pleven, Plovdiv, Sofia
- Életkor
- 40 év and over
- People
- 3040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - 3. fázisTaking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Pleven, Plovdiv, Ruse, Sofiya, Stara Zagora
- Életkor
- 18 év and over
- People
- 1088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Pleven, Plovdiv, Sofiya, Stara Zagora
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Pleven, Plovdiv, Sofia, Sofiya, Varna
- Életkor
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693 - 3. fázisNot yet taking people in BulgáriaA Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
- Where
- Lovech, Pleven, Plovdiv, Sliven
- Életkor
- 18 év and over
- People
- 705 worldwide
- Run by
- Can-Fite BioPharma
See details and how to joinNCT06643260 · EU 2024-519919-34-00